Apex Biotechnology Corp. (TPE:1733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.70
0.00 (0.00%)
Apr 29, 2026, 1:30 PM CST

Apex Biotechnology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
567.09532.69382.05331.71555.33
Upgrade
Trading Asset Securities
77.2866.161.8765.8369.72
Upgrade
Cash & Short-Term Investments
644.37598.78443.91397.53625.05
Upgrade
Cash Growth
7.61%34.89%11.67%-36.40%-24.05%
Upgrade
Accounts Receivable
437.8346.64288.39486.77474.41
Upgrade
Other Receivables
9.818.085.7210.1213.97
Upgrade
Receivables
447.61354.72294.11496.89488.38
Upgrade
Inventory
561.83662.49747.71739.25628.59
Upgrade
Prepaid Expenses
18.8224.7818.511911.06
Upgrade
Other Current Assets
0.982.292.41.816.78
Upgrade
Total Current Assets
1,6741,6431,5071,6541,760
Upgrade
Property, Plant & Equipment
652.64695.81720.59766.08794.12
Upgrade
Other Intangible Assets
35.7139.644.2269.14106.48
Upgrade
Long-Term Deferred Tax Assets
12.89.244.243.620.43
Upgrade
Other Long-Term Assets
41.0632.2321.3221.389.58
Upgrade
Total Assets
2,4162,4202,2972,5152,670
Upgrade
Accounts Payable
231.7239.03156.22289.69343.89
Upgrade
Accrued Expenses
154.93142.25133.43150.55148.07
Upgrade
Short-Term Debt
--3050150
Upgrade
Current Portion of Leases
7.699.037.28.016.88
Upgrade
Current Income Taxes Payable
25.8824.5246.2436.9240.12
Upgrade
Current Unearned Revenue
7.2358.286.629.0493.06
Upgrade
Other Current Liabilities
4.624.683.676.353.87
Upgrade
Total Current Liabilities
432.05477.78383.35570.55785.89
Upgrade
Long-Term Leases
101.98113.93116.2122.67127.66
Upgrade
Long-Term Deferred Tax Liabilities
10.823.540.043.12.88
Upgrade
Other Long-Term Liabilities
0.470.470.480.490.48
Upgrade
Total Liabilities
545.32595.7500.07696.81916.91
Upgrade
Common Stock
999.5999.5999.5999.5999.5
Upgrade
Additional Paid-In Capital
--68.3768.3768.37
Upgrade
Retained Earnings
791.23744.06718.87739.95682.34
Upgrade
Comprehensive Income & Other
78.9880.049.699.512.52
Upgrade
Total Common Equity
1,8701,8241,7961,8171,753
Upgrade
Minority Interest
0.770.630.50.570.82
Upgrade
Shareholders' Equity
1,8701,8241,7971,8181,754
Upgrade
Total Liabilities & Equity
2,4162,4202,2972,5152,670
Upgrade
Total Debt
109.67122.96153.4180.68284.55
Upgrade
Net Cash (Debt)
534.69475.83290.52216.85340.5
Upgrade
Net Cash Growth
12.37%63.79%33.97%-36.31%10.11%
Upgrade
Net Cash Per Share
5.324.742.902.153.22
Upgrade
Filing Date Shares Outstanding
99.9599.9599.9599.9599.95
Upgrade
Total Common Shares Outstanding
99.9599.9599.9599.9599.95
Upgrade
Working Capital
1,2421,1651,1231,084973.97
Upgrade
Book Value Per Share
18.7118.2517.9718.1817.54
Upgrade
Tangible Book Value
1,8341,7841,7521,7481,646
Upgrade
Tangible Book Value Per Share
18.3517.8517.5317.4916.47
Upgrade
Land
261.68261.68261.68261.68261.68
Upgrade
Buildings
605.02605.02604.13604.13601.96
Upgrade
Machinery
816.08806.49789.71777.35754.25
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.